Suven Life Sciences Q2 Results
- BSE: 530239
- NSE: SUVEN
- ISIN: INE495B01038
- Sector: Biotechnology & Drugs
BSE
118.5
1.05 (0.89%)
1.05 (0.89%)Volume10.13 K
Updated: Mon 25 Nov, 2024 | 15:29:05
NSE
118.51.03 (0.88%)
1.03 (0.88%)Volume1.38 L
Updated: Mon 25 Nov, 2024 | 15:29:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹2.57 Cr.(155.76%)
- Operating Profit₹-53.66 Cr.(67.57%)
- Profit After Tax₹-49.64 Cr.(77.05%)
- Operating Margin-2085.73%(258.91%)
Note: Comparison is on YoY basis
Quarterly - Suven Life Sciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 2.57 | 3.80 | -% | 3.06 | -% |
| Selling/ General/ Admin Expenses Total | 5.20 | 5.28 | -% | 4.45 | -% |
| Depreciation/ Amortization | 1.46 | 1.66 | -% | 1.73 | -% |
| Other Operating Expenses Total | 1.99 | 1.75 | -% | 1.62 | -% |
| Total Operating Expense | 56.24 | 33.48 | -% | 20.84 | -% |
| Operating Income | -53.66 | -29.68 | -% | -17.78 | -% |
| Net Income Before Taxes | -49.64 | -24.09 | -% | -12.68 | -% |
| Net Income | -49.64 | -24.09 | -% | -12.68 | -% |
| Diluted Normalized EPS | -2.27 | -1.10 | -% | -0.92 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST